IBDEI0FX ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7670,1,3,0)
 ;;=3^Marginal Corneal Ulcer
 ;;^UTILITY(U,$J,358.3,7670,1,4,0)
 ;;=4^370.01
 ;;^UTILITY(U,$J,358.3,7670,2)
 ;;=Marginal Corneal Ulcer^268908
 ;;^UTILITY(U,$J,358.3,7671,0)
 ;;=375.30^^49^561^47
 ;;^UTILITY(U,$J,358.3,7671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7671,1,3,0)
 ;;=3^Dacrocystitis
 ;;^UTILITY(U,$J,358.3,7671,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,7671,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,7672,0)
 ;;=376.01^^49^561^69
 ;;^UTILITY(U,$J,358.3,7672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7672,1,3,0)
 ;;=3^Orbital Cellulitis
 ;;^UTILITY(U,$J,358.3,7672,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,7672,2)
 ;;=Orbital Cellulitis^259068
 ;;^UTILITY(U,$J,358.3,7673,0)
 ;;=682.0^^49^561^6
 ;;^UTILITY(U,$J,358.3,7673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7673,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,7673,1,4,0)
 ;;=4^682.0
 ;;^UTILITY(U,$J,358.3,7673,2)
 ;;=Cellulitis of Face^271888
 ;;^UTILITY(U,$J,358.3,7674,0)
 ;;=473.9^^49^561^84
 ;;^UTILITY(U,$J,358.3,7674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7674,1,3,0)
 ;;=3^Sinusitis,Unspec
 ;;^UTILITY(U,$J,358.3,7674,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,7674,2)
 ;;=Sinusitis^123985
 ;;^UTILITY(U,$J,358.3,7675,0)
 ;;=017.30^^49^561^90
 ;;^UTILITY(U,$J,358.3,7675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7675,1,3,0)
 ;;=3^Tuberculosis,Eye
 ;;^UTILITY(U,$J,358.3,7675,1,4,0)
 ;;=4^017.30
 ;;^UTILITY(U,$J,358.3,7675,2)
 ;;=^122722
 ;;^UTILITY(U,$J,358.3,7676,0)
 ;;=076.9^^49^561^88
 ;;^UTILITY(U,$J,358.3,7676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7676,1,3,0)
 ;;=3^Trachoma,Unspec
 ;;^UTILITY(U,$J,358.3,7676,1,4,0)
 ;;=4^076.9
 ;;^UTILITY(U,$J,358.3,7676,2)
 ;;=^120805
 ;;^UTILITY(U,$J,358.3,7677,0)
 ;;=077.0^^49^561^31
 ;;^UTILITY(U,$J,358.3,7677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7677,1,3,0)
 ;;=3^Conjunctivitis,Inclusion
 ;;^UTILITY(U,$J,358.3,7677,1,4,0)
 ;;=4^077.0
 ;;^UTILITY(U,$J,358.3,7677,2)
 ;;=^27600
 ;;^UTILITY(U,$J,358.3,7678,0)
 ;;=077.1^^49^561^61
 ;;^UTILITY(U,$J,358.3,7678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7678,1,3,0)
 ;;=3^Keratoconjunctivitis,Epidemic EKC
 ;;^UTILITY(U,$J,358.3,7678,1,4,0)
 ;;=4^077.1
 ;;^UTILITY(U,$J,358.3,7678,2)
 ;;=^41251
 ;;^UTILITY(U,$J,358.3,7679,0)
 ;;=077.8^^49^561^37
 ;;^UTILITY(U,$J,358.3,7679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7679,1,3,0)
 ;;=3^Conjunctivitis,Viral,Oth
 ;;^UTILITY(U,$J,358.3,7679,1,4,0)
 ;;=4^077.8
 ;;^UTILITY(U,$J,358.3,7679,2)
 ;;=^88239
 ;;^UTILITY(U,$J,358.3,7680,0)
 ;;=078.5^^49^561^46
 ;;^UTILITY(U,$J,358.3,7680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7680,1,3,0)
 ;;=3^Cytomegaloviral Disease
 ;;^UTILITY(U,$J,358.3,7680,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,7680,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,7681,0)
 ;;=090.3^^49^561^59
 ;;^UTILITY(U,$J,358.3,7681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7681,1,3,0)
 ;;=3^Keratitis,Interstitial,Syphilitic
 ;;^UTILITY(U,$J,358.3,7681,1,4,0)
 ;;=4^090.3
 ;;^UTILITY(U,$J,358.3,7681,2)
 ;;=^266697
 ;;^UTILITY(U,$J,358.3,7682,0)
 ;;=091.50^^49^561^93
 ;;^UTILITY(U,$J,358.3,7682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7682,1,3,0)
 ;;=3^Uveitis Syphilitica,Unspec
 ;;^UTILITY(U,$J,358.3,7682,1,4,0)
 ;;=4^091.50
 ;;^UTILITY(U,$J,358.3,7682,2)
 ;;=^266715
 ;;^UTILITY(U,$J,358.3,7683,0)
 ;;=094.83^^49^561^83
 ;;^UTILITY(U,$J,358.3,7683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7683,1,3,0)
 ;;=3^Retinochoroiditis,Dissem,Syphilitic
 ;;^UTILITY(U,$J,358.3,7683,1,4,0)
 ;;=4^094.83
